Literature DB >> 15251082

Development of diagnostic criteria for psoriatic arthritis: methods and process.

William J Taylor1, Philip S Helliwell.   

Abstract

Psoriatic arthritis is an inflammatory arthritis associated with psoriasis but this simple definition obscures the difficulty in defining the condition for epidemiologic purposes. Since the original description by Moll and Wright, a number of other classification criteria have been published. None of these have been fully evaluated and only one has been developed using patient derived data. Methodologic problems in developing classification criteria--their purpose, utility, and accuracy--are discussed in relation to a new International collaboration, the International Multicentre Validation of Diagnostic Criteria for Psoriatic Arthritis (CASPAR).

Entities:  

Mesh:

Year:  2004        PMID: 15251082     DOI: 10.1007/s11926-004-0042-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  25 in total

1.  Epidemiology of the sheep cell agglutination test.

Authors:  J BALL; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-09       Impact factor: 19.103

2.  ARA NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE).

Authors:  B S BLUMBERG; J J BUNIM; E CALKINS; C L PIRANI; N J ZVAIFLER
Journal:  Arthritis Rheum       Date:  1964-02

3.  [The development and testing of diagnostic criteria in psoriatic arthritis].

Authors:  E R Agababova; V B Badokin; Sh Erdes; N M Mylov; E M Aseeva
Journal:  Ter Arkh       Date:  1989       Impact factor: 0.467

Review 4.  Latent class analysis in medical research.

Authors:  A K Formann; T Kohlmann
Journal:  Stat Methods Med Res       Date:  1996-06       Impact factor: 3.021

5.  Subtyping of juvenile idiopathic arthritis using latent class analysis. British Paediatric Rheumatology Group.

Authors:  E Thomas; J H Barrett; R P Donn; W Thomson; T R Southwood
Journal:  Arthritis Rheum       Date:  2000-07

6.  Operational definitions of schizophrenia: what do they identify?

Authors:  M A Young; M A Tanner; H Y Meltzer
Journal:  J Nerv Ment Dis       Date:  1982-08       Impact factor: 2.254

7.  Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients.

Authors:  B Fournié; L Crognier; C Arnaud; L Zabraniecki; V Lascaux-Lefebvre; V Marc; E Ginesty; V Andrieu; C Dromer; A Fournié
Journal:  Rev Rhum Engl Ed       Date:  1999-10

8.  Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report.

Authors:  C Biondi Oriente; R Scarpa; A Pucino; P Oriente
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

9.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

10.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09
View more
  6 in total

Review 1.  New treatments for inflammatory rheumatic disease.

Authors:  Carlo Selmi; Elena Generali; Marco Massarotti; Gerolamo Bianchi; Carlo A Sciré
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis.

Authors:  B Vander Cruyssen; I E A Hoffman; H Zmierczak; M Van den Berghe; E Kruithof; L De Rycke; H Mielants; E M Veys; D Baeten; F De Keyser
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

3.  Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.

Authors:  Maryam M Asgari; Jashin J Wu; Joel M Gelfand; Craig Salman; Jeffrey R Curtis; Leslie R Harrold; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-05-02       Impact factor: 2.890

Review 4.  Classification and Outcome Measures for Psoriatic Arthritis.

Authors:  Ying Ying Leung; Alexis Ogdie; Ana-Maria Orbai; William Tillett; Laura C Coates; Vibeke Strand; Philip Mease; Dafna D Gladman
Journal:  Front Med (Lausanne)       Date:  2018-09-06

Review 5.  Sex-Based Medicine Meets Psoriatic Arthritis: Lessons Learned and to Learn.

Authors:  Nicola Luigi Bragazzi; Charlie Bridgewood; Abdulla Watad; Giovanni Damiani; Dennis McGonagle
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

6.  Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response.

Authors:  Maria Sole Chimenti; Paola Triggianese; Alessandra Narcisi; Barbara Marinari; Miriam Teoli; Sara Faleri; Annalisa Arcese; Roberto Perricone; Antonio Costanzo
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.